Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Employment as a health promotion intervention for persons with multiple sclerosis.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
The ICF as a framework to collect and interpret data on the extent and variety of disability in neurological conditions.
Deleterious versus protective autoimmunity in multiple sclerosis.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing.
Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
Paroxysmal chorea as a relapse of myelopathy in a patient with neuromyelitis optica.
Epileptic Seizures in Early-onset Multiple Sclerosis.
Spasticity in multiple sclerosis: results of a patient survey.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Vitamin D and multiple sclerosis.
Defining Encephalopathy in Acute Disseminated Encephalomyelitis.
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.
Monitoring neuromyelitis optica activity.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
High cumulative JC virus seroconversion rate during long-term use of natalizumab.
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.
Exploring the potential of public proteomics data.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients.

Pages